Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Drug Profile

Choriogonadotropin alfa biosimilar - Dong-A ST

Alternative Names: DA 3803; r-hCG

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A ST
  • Class Gonadotropins; Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormone vaccines; Placental hormones; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Female infertility

Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 11 Sep 2018 No development reported - Preregistration for Female infertility in South Korea (SC)
  • 26 May 2015 Choriogonadotropin alfa biosimilar - Dong-A ST is available for licensing in World as of 26 May 2015. http://en.donga-st.com
  • 26 May 2015 Dong A announces intention to submit NDA to KFDA (Dong-A ST 1Q report, May 2015)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days